Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
about
Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the futureIL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophiliaSPINART study: validation of the extended magnetic resonance imaging scale for evaluation of joint status in adult patients with severe haemophilia A using baseline data.Joint pathology and platelet-rich plasma therapies.Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in miceNuclear factor (NF)-κB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia.Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS): peering into the cup of Jamshid.MALDI imaging of predictive ferritin, fibrinogen and proteases in haemophilic arthropathy.Vascular remodeling underlies rebleeding in hemophilic arthropathyInflammatory focal bone destruction in femoral heads with end-stage haemophilic arthropathy: a study on clinic samples with micro-CT and histological analysesPathophysiology of Hemophilic Arthropathy.Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.Advances and challenges in hemophilic arthropathy.The results of Oxford unicompartmental knee arthroplasty in the United States: a mean ten-year survival analysis.Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports.Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy.Connective tissue growth factor (CTGF/CCN2) in haemophilic arthropathy and arthrofibrosis: a histological analysis.Repeated autologous intraarticular blood injections as an animal model for joint pain in haemophilic arthropathy.Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis.Exploring the biological basis of haemophilic joint disease: experimental studies.Management of joint bleeding in hemophilia.Hemophilia and prophylaxis.Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.Platelet-rich plasma for managing pain and inflammation in osteoarthritis.The burden of bleeding in haemophilia: is one bleed too many?Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States.Considerations in individualizing prophylaxis in patients with haemophilia A.With blood in the joint - what happens next? Could activation of a pro-inflammatory signalling axis leading to iRhom2/TNFα-convertase-dependent release of TNFα contribute to haemophilic arthropathy?Optimal management of hemophilic arthropathy and hematomasVarious regimens for prophylactic treatment of patients with haemophilia.Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial.Safety of radiation exposure after radiosynovectomy in paediatric patients with haemophilia.The detrimental effects of iron on the joint: a comparison between haemochromatosis and haemophilia.Rapid rFVIIa enhanced on-demand dosing in haemophilia inhibitor patients.Effect of late prophylaxis in hemophilia on joint status: a randomized trial.Patient dissatisfaction after total knee arthroplasty for hemophilic arthropathy and osteoarthritis (non-hemophilia patients).Optimising musculoskeletal care for patients with haemophilia.Osteochondral repair in hemophilic ankle arthropathy: from current options to future perspectives.
P2860
Q26853631-A57CB2B0-E5B6-4AA4-8093-52D235B0E0DDQ30439206-6ECF3707-FF76-4D35-B096-97A9CB0A1F54Q31131582-49104096-B95F-4121-8404-E416CF9731FEQ34240837-581F8809-0F48-41C0-80C6-D630CB6E1BD8Q34383596-999DF60E-84F3-4837-BCC8-3C487F7B0AE0Q34508572-70AE0CBD-B6CB-424A-9C49-52345FD280ABQ34876876-2957AC8F-9218-40A4-8B83-824A7C5F7360Q35147290-E6A14C64-9ADF-425E-8A1C-2373954FC389Q35171864-E30DBC1D-1E81-4492-9B95-76D8F91B91E6Q36199877-9E678E65-69D3-42E4-80E3-5EE0EEEDC8CEQ36216958-F6C1DE6B-1999-4F9C-A4C2-CCCFEBB45622Q36414215-DA23CCAA-991E-4A84-8A36-D7E1CE10C26EQ36890872-7FC32936-C4C2-41F1-A7A1-DEA22A3B9782Q37212741-E803A10E-733F-4188-BAA7-091E9514D868Q37279529-BB553E83-8C4C-4213-B5A6-0E9A236BCFA9Q37304781-6AF3DC26-C909-4B51-A114-5F104B977B4EQ37320598-25AD0A8A-5F5D-4275-8E36-A86AD1211A56Q37433037-32DEFC81-8265-4323-95E0-C8E74C1E8835Q37514407-65CB021E-01A6-447B-AF25-8C0B8F390933Q37690749-8E8A5FDD-C200-424D-BCB2-6FA9CCB954A9Q37857364-49EACEA4-5034-4C92-9C72-993F64B608E7Q37951686-1488897A-F260-4373-8FE7-3E88874A7DFFQ38044778-31B3D17A-1A77-42A6-B7E6-35B1376D0376Q38056467-445D93FC-55F4-465C-A03C-84F54502F713Q38079624-A43C1256-1577-44B4-A5BD-E5133AC6137FQ38147906-9F19FFF2-6A15-4452-A277-203A81904983Q38182702-C978DB01-3FFA-40BC-A768-E8FA0EA5FCA6Q38182706-236A6AA2-539D-4F19-979B-2F8200CB53DBQ38203021-D8C8395A-7328-4916-BC6F-41E361CB9D69Q38206847-2E0C3112-E070-4823-821E-24C76D91BAA2Q38266031-E8FD91D2-CAFA-4C79-AE33-D219295B4923Q38308200-DF00FEE2-2E28-41AD-8B51-5C8D0A06544EQ38390937-CB024480-3D5C-4197-86DD-110E43341AADQ38411820-237F9C8E-AD36-4656-9E88-A4C236744D5CQ38432393-EB3A8BE1-E2F0-4EA9-8C46-1744B7450E56Q38546790-C41B3611-B867-4D31-A758-4762BDADE2B5Q38610808-38B65091-F793-4003-BF7D-C3391318A3D0Q38631459-67BCF9DC-04FA-4554-AE35-FE37CBBFA4C4Q38672487-0EBF04DC-EF5B-452C-901F-8DE1378E6721Q38746047-9EE65E4F-9B93-4FFF-908D-98EA09A82CD4
P2860
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
@en
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
@nl
type
label
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
@en
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
@nl
prefLabel
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
@en
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
@nl
P2860
P1476
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
@en
P2093
L A Valentino
P2860
P304
P356
10.1111/J.1538-7836.2010.03962.X
P577
2010-09-01T00:00:00Z